News Daily News RECORD4 Trial of Rivaroxaban, Published in 2009, Still Turning Heads Todd Neale January 19, 2023
News Daily News PREVENT CLOT Supports Aspirin for VTE Prevention in Trauma Fractures L.A. McKeown January 18, 2023
News Daily News PCSK9 Inhibition Shows Promise for Severe COVID-19 in Pilot Trial Todd Neale January 18, 2023
News Daily News Medical Devices Cleared on Faulty Predicates More Likely to be Recalled Michael O'Riordan January 17, 2023
News Conference News ISET 2023 For Vascular Labs, Accreditation Drives Quality and Objectivity Caitlin E. Cox January 17, 2023
News Daily News Sustained LDL-Cholesterol Reductions With Inclisiran: ORION-3 Michael O'Riordan January 16, 2023
News Daily News Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees Michael O'Riordan January 05, 2023
News Daily News Lasers a Valuable Tool to Retrieve Embedded IVC Filters: Multicenter Study Caitlin E. Cox December 30, 2022
News Daily News Effect of Intensive BP-Lowering on Cardiac Biomarkers Varies: SPRINT Analysis Todd Neale December 23, 2022
News Daily News It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies Todd Neale December 21, 2022
News Daily News Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke Todd Neale December 21, 2022
News Daily News OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer L.A. McKeown December 16, 2022
News Daily News Cardiac Imaging’s Carbon Footprint: Time for Awareness and Action Yael L. Maxwell December 16, 2022
News Daily News FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil Michael O'Riordan December 14, 2022
News Daily News Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement Todd Neale December 09, 2022
News Daily News Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths Michael O'Riordan December 08, 2022